• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Day Market Update: Crud Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher

    4/19/22 12:37:08 PM ET
    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Specialty Chemicals
    Consumer Durables
    Oilfield Services/Equipment
    Energy
    Get the next $CMPI alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

    The Dow traded up 1.13% to 34,800.08 while the NASDAQ rose 1.82% to 13,575.33. The S&P also rose, gaining, 1.27% to 4,447.64.

    Also check this: 4 Stocks Under $5 Insiders Are Aggressively Buying


    Leading and Lagging Sectors


    Consumer discretionary shares jumped by 2.5% on Tuesday. Meanwhile, top gainers in the sector included Sono Group N.V. (NASDAQ:SEV), up 47% and (NASDAQ:HOUR) up 10%.


    In trading on Tuesday, energy shares fell 1.2%.


    Top Headline


    Johnson & Johnson (NYSE:JNJ) reported better-than-expected earnings for its first quarter, but suspended sales forecast for COVID-19 vaccine.

    Johnson & Johnson reported Q1 FY22 adjusted earnings of $2.67 per share, up 3.1% Y/Y and ahead of the consensus of $2.61. Net sales increased 5% Y/Y (7.9% on an operational basis) to $23.43 billion, missing the consensus of $23.67 billion.

    Johnson & Johnson expects an FY22 adjusted profit forecast of $10.15 - $10.35 per share, lower than the prior forecast of $10.40 - $10.60. The consensus estimate is $10.51. The Company expects sales of $97.3 billion – $98.3 billion, versus the consensus of $$99.31 billion. JNJ has suspended its sales forecast for the COVID-19 vaccine due to global supply surplus and demand uncertainty.


    Equities Trading UP


    Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) shares shot up 330% to $10.44 after Regeneron announced a deal to acquire the company for $10.50 per share in cash.


    Shares of Super Micro Computer, Inc. (NASDAQ:SMCI) got a boost, shooting 21% to $44.19 after the company raised its Q3 guidance above analyst estimates.


    ToughBuilt Industries, Inc. (NASDAQ:TBLT) shares were also up, gaining 64% to $0.2406 as the company posted a narrower FY21 loss.


    Equities Trading DOWN

    System1, Inc. (NYSE:SST) shares tumbled 34% to $13.51 as the company disclosed a previously-issued (from Feb. 9, 2022) shelf registration statement went into effect.


    Shares of Enservco Corporation (NYSE:ENSV) were down 22% to $2.8484. Enservco shares gained 38% on Monday after the company announced the delay of its 2021 10-K filing to adjust for its utilization of certain deferred tax liabilities in 2021.


    DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was down, falling 13% to $42.61 after the company issued Q1 2022 adjusted EPS guidance below estimates and announced the appointment of John Groetelaars as Interim Chief Executive Officer.


    Also check out: Twitter And 4 Other Stocks Insiders Are Selling


    Commodities

    In commodity news, oil traded down 5.3% to $102.49, while gold traded down 1.6% to $1,954.10.


    Silver traded down 3.4% Tuesday to $25.25 while copper fell 2% to $4.7050.



    Euro zone


    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.66%, London’s FTSE 100 fell 0.06%, while Spain’s IBEX 35 Index rose 0.01%. The German DAX slipped 0.01%, French CAC 40 fell 0.63% and Italy’s FTSE MIB Index dipped 0.97%.


    Economics


    Housing starts in the US rose 0.3% to an annualized rate of 1.793 million in March, while building permits rose 0.4% to an annual rate of 1.873 million.


    Federal Reserve Bank of Minneapolis President Neel Kashkari will speak at 8:00 p.m. ET.

    Check out this: 4 Stocks Under $5 Insiders Are Aggressively Buying


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 82,377,150 cases with around 1,015,790 deaths. India confirmed a total of at least 43,045,520 cases and 521,990 deaths, while Brazil reported over 30,261,080 COVID-19 cases with 662,070 deaths. In total, there were at least 505,279,780 cases of COVID-19 worldwide with more than 6,225,190 deaths.

    Get the next $CMPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMPI
    $ENSV
    $HOUR
    $JNJ

    CompanyDatePrice TargetRatingAnalyst
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Johnson & Johnson
    $JNJ
    1/28/2026$262.00Equal-Weight → Overweight
    Morgan Stanley
    Super Micro Computer Inc.
    $SMCI
    1/13/2026$26.00Sell
    Goldman
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    Johnson & Johnson
    $JNJ
    11/13/2025$230.00Sector Outperform
    Scotiabank
    DENTSPLY SIRONA Inc.
    $XRAY
    11/7/2025Outperform → Mkt Perform
    William Blair
    Super Micro Computer Inc.
    $SMCI
    11/6/2025Hold → Buy
    Argus
    Johnson & Johnson
    $JNJ
    10/20/2025$203.00Neutral → Outperform
    Daiwa Securities
    More analyst ratings

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Varon Leslie F bought $99,999 worth of shares (9,337 units at $10.71), increasing direct ownership by 19% to 57,343 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    11/25/25 5:26:33 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Large owner Cee Holdings Trust bought $80,630 worth of shares (11,015 units at $7.32), increasing direct ownership by 1% to 919,555 units (SEC Form 4)

    4 - System1, Inc. (0001805833) (Issuer)

    8/26/25 7:56:50 PM ET
    $SST
    Computer Software: Programming Data Processing
    Technology

    Large owner Cee Holdings Trust bought $206,983 worth of shares (31,735 units at $6.52), increasing direct ownership by 4% to 908,540 units (SEC Form 4)

    4 - System1, Inc. (0001805833) (Issuer)

    8/21/25 5:46:14 PM ET
    $SST
    Computer Software: Programming Data Processing
    Technology

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)

    Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timelineThe designation is supported by a Phase 2 study in which nipocalimab demonstrated reduction in lupus disease activity and potential for steroid sparing Systemic lupus erythematosus is a debilitating, chronic autoantibody-driven disease affecting multiple organs, with limited treatment options and risk of irreversible organ damage Johnson & Johnson is actively enrolling patients in a Phase 3 study of adults with active systemic lupus erythematosusSPRING HOUSE, Pa., March 3, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced that nipocalimaba was

    3/3/26 8:03:00 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aptera Motors Completes First Vehicle off Validation Assembly Line

    CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV), a solar mobility company advancing ultra-efficient transportation, has completed the first vehicle off its validation assembly line, marking a major operational milestone as the company progresses toward regulatory certification and initial customer deliveries. The company's low-volume validation assembly line represents Aptera's transition from hand-built validation vehicles to a structured assembly line process. The line consists of 14 dedicated stations, where vehicles are assembled by a team of vehicle line technicians, enabling repeatable builds, process verification, and optimization. Vehicles

    3/3/26 8:00:00 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

    Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14th to review first-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team. Investors and other interested parties can access the webcast/conference call in the following ways: The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of

    3/2/26 4:30:00 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    SEC Filings

    View All

    Aptera Motors Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aptera Motors Corp (0001786471) (Filer)

    3/3/26 8:05:44 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    SEC Form 10-K filed by DENTSPLY SIRONA Inc.

    10-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:54:01 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:13:30 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 21, 2023 - FDA Roundup: July 21, 2023

    For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

    7/21/23 4:02:23 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

    For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

    5/5/22 4:51:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 18, 2021 - Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

    For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. The statement is attributable to Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention (CDC); Dr. Janet Woodcock, Acting Commissione

    8/18/21 1:06:11 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Johnson & Johnson upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Johnson & Johnson from Equal-Weight to Overweight and set a new price target of $262.00

    1/28/26 7:11:28 AM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman resumed coverage on Super Micro Computer with a new price target

    Goldman resumed coverage of Super Micro Computer with a rating of Sell and set a new price target of $26.00

    1/13/26 9:18:14 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Mckeon Brian P

    3 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/2/26 5:15:27 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Forbes James D

    3 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/2/26 5:13:57 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    President, CEO & Member of BOD Scavilla Daniel T covered exercise/tax liability with 1,194 shares, decreasing direct ownership by 7% to 16,750 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    2/26/26 4:31:06 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

    CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device

    1/12/26 9:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Financials

    Live finance-specific insights

    View All

    Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

    Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14th to review first-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team. Investors and other interested parties can access the webcast/conference call in the following ways: The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of

    3/2/26 4:30:00 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

    AUSTIN, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative early-stage programs. After years of capital flowing into preclinical platforms with uncertain timelines, investors and acquirers are gravitating toward programs with established safety and efficacy data that can accelerate commercialization pathways. This evolving landscape naturally places companies such as Oncotelic Therapeutics Inc. (OTCQB:OTLC) (profile), which holds multiple clinical-stage and late-stage program

    2/17/26 8:30:00 AM ET
    $ARWR
    $JNJ
    $MGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $CMPI
    $ENSV
    $HOUR
    $JNJ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by ToughBuilt Industries Inc.

    SC 13G/A - Toughbuilt Industries, Inc (0001668370) (Subject)

    11/14/24 7:29:15 PM ET
    $TBLT
    Industrial Machinery/Components
    Consumer Discretionary